Seeking Alpha

  Boston Therapeutics Inc (BTHE) - OTCQB

  • QualityStocks | Send Message 22 Jan

    Boston Therapeutics, Inc. (BTHE) Prepares For Third Phase Trial Of PAZ320 $BTHE
      BTHE vs. ETF Alternatives
      Company Description
      Boston Therapeutics, headquartered in Manchester, NH, (OTCQB: BTHE) is a leader in the field of designing drugs using complex carbohydrates. The Company's product pipeline is focused on developing and commercializing therapeutic molecules for diabetes, including: BTI-320, a non-systemic chewable... More
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States